Cisplatin plus capecitabine concomitant with intensity-modulated radiation therapy in non-metastatic anal squamous cell carcinoma: the experience of a single research cancer center

BACKGROUND AND AIMS: The standard treatment of non-metastatic anal squamous cell carcinoma (ASCC) consists of chemotherapy with mitomycin (MMC) plus 5-fluorouracil (5FU) for 1–2 cycles concomitant with pelvic radiotherapy. Subsequent studies introduced cisplatin (CDDP) combined with 5FU, with unclea...

Descripción completa

Detalles Bibliográficos
Autores principales: Rotundo, Maria Saveria, Zampino, Maria Giulia, Ravenda, Paola Simona, Bagnardi, Vincenzo, Peveri, Giulia, Dell’Acqua, Veronica, Surgo, Alessia, Trovato, Cristina, Bottiglieri, Luca, Bertani, Emilio, Petz, Wanda Luisa, Fumagalli Romario, Uberto, Fazio, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364808/
https://www.ncbi.nlm.nih.gov/pubmed/32728394
http://dx.doi.org/10.1177/1758835920940945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364808/
https://www.ncbi.nlm.nih.gov/pubmed/32728394
http://dx.doi.org/10.1177/1758835920940945

Ejemplares similares